CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

November 5, 2021 · earnings

NKTR earnings: a negative outcome, -19.2%

On November 5, 2021, Nektar Therapeutics reached its earnings. The result was a negative outcome, and the stock moved -19.2% in the window around the event.

The move

$249.74
1d before
$201.74
Event day
$201.74
1d after
$203.69
5d after

Pre-catalyst setup

+3.4%
30-day run-up
4902%
30-day volatility
1.2×
volume spike